Logo
Give Your Eyes a Little Bit of Heaven!
 | 
Office Hours

OptiLIGHT with Lumenis patented Optimal Pulse Technology uses precise, intense broad spectrum light to address the inflammation - one of the key underlingin factors in dry eye disease due to MGD.

OptiLIGHT is specifically developed to reach the delicate contours of the treated area safely, effectively and gently. OptiLIGHT sets new treatment standards and helps patients find a real solution for their dry eyes.

THE FIRST AND ONLY LIGHT THERAPY,
FDA-APPROVED FOR DRY EYE MANAGEMENT



Suffering from Dry, Itchy, Red, or Burning Eyes

You are not alone. Between 30 to 40 million Americans are estimated to suffer from Dry Eye Disease. Meibomian Gland Dysfunction (MGD) is considered a leading cause in Dry Eye Disease, accounting for about 86% of cases.

Dry Eye Disease due to MGD can have a significant impact on your quality of life, leading to foreign body sensation, pain, blury vision, dry or watery eyes.

We know how tough and frustrating this can be - and you deserve a solution.

A Real Solution For Dry Eyes

OptiLIGHT's novel Optimal Pulse Technology (OPT®) provides a transformative, safe, and efficacious way to improve signs of Dry Eye disease due to MGD.

Gentle, Fast, No-Downtime

Immediately following treatment, you may experience some redness. This will usually disappear within a few hours. You can return to your daily activities and apply makeup straight away in most cases.

You will be advised to stay out of direct sunlight for a few days and to apply sunscreen. Patients usually report an imporvement after their 2nd or 3rd treatment. Maintenance treatments are usually recommended every 6-12 months, to ensure the best long-term results.

Optimal results in just a few short sessions
  • A course of treatment typically includes 4 sessions spaced 204 weeks apart.
  • Each session usually takes only 10-15 minutes.
  • During the treatment your practitioner will apply a coupling gel on the treatment area and cover you eyes with shields.
  • You may experience a warm sensation as light is applied to the skin, the treatment is gentle with minimum disconfort.
  • OptiLIGHT is often followered by Meibomian Glands expression.


Risk Information

Lumenis energy-based treatments are not suitable for everyone and, like every treatment, can carry some risks. Treatment with OptiLIGHT is contraindicated for patients with the following conditions in the treatment area: active infections, dysplastic nevi, tattoos, significant concurrent skin inflammation (excluding rosacea or acne), active cold sores, open lacerations, abrasions, and prolonged sun-exposure. Caution is advised for patients with a compromised immune system, coagulation disorders, photosenitivity, hormonal disorders, or a history of Herpes simplex near the treatment area. Patients' eyes must be occluded with eye shields during the treatment. Be sure to consult with your treatment provider to make sure that this treatment is the right choice for you.

OFFICE HOURS    
Mon
*8:15 - 5:30
Tue
*8:15 - 5:30
Wed
*8:15 - 5:30
Thu
*8:15 - 5:30
*Closed for lunch 1:00 - 1:45
Fri
Closed
Sat
Closed
Sun
Closed
300 Association Drive
Charleston, WV 25311
Map it!

(304) 342-5900
Facebook   Twitter   Instagram
Greenbrier Vision Center, Inc. 300 Association Drive Charleston, WV 25311 Phone: (304) 342-5900 Fax: (304) 342-6257

Greenbrier Vision Center proudly serves Charleston, WV and the surrounding areas of Dunbar, Sissonville, Big Chimney, Chelyan, St. Albans, Scott Depot, Kenna, Branchland and Kanawha Falls.

Section 1557 of the Affordable Care Act prohibits discrimination on the basis of race, color, national origin, sex, age or disability in certain health programs and activities. As of October 16, 2016, regulations require most optometry practices to prominently display their non-discrimination policy at their physical location, on their website homepage, and on all significant communications and publications, all of which must include taglines, in the 15 most prevalent non-English languages in the state, stating the non-discrimination policy of the practice.

Nondiscrimination Statement

© 2025 All content is the property of Greenbrier Vision Center, Inc. ™ & assoc. vendors.
Website Powered and Developed by EyeVertise.com